The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in ...

Professors Svetlana Mojsov and Carlos Kenig, among other eminent figures, were selected to win the 48th session of the prize.

"Dry January" is getting replaced by something a lot more modern: half of Americans say taking GLP-1 medications is the next ...

Format Comparison for Needle-Free GLP-1 Options, Administration Preferences, and Telehealth Access PathwaysHOUSTON, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational ...

Professor Svetlana Mojsov was announced this year's King Faisal Prize in Medicine laureate for her groundbreaking discoveries that are reshaping how ...

Hims & Hers trades at FWD EV/Sales of 3.45x and FWD EV/EBITDA of 25.85x, with FY2030 targets implying further upside for ...

GLP-1 drugs like semaglutide and tirzepatide have rewritten the rules of weight loss and diabetes care, but the story turns ...

The next step in the evolution of generative AI technology will rely on ‘world models’ to improve physical outcomes in the ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

AI innovations, such as the ASCO Guidelines Assistant, enhance evidence-based decision-making by providing quick access to critical guidelines. ASCO 2025 highlighted breakthroughs, including improved ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ...

Jess Loren remembers loving the taste of Cap'n Crunch cereal. Coca-Cola. Snickers bars. But now, instead of a sweetness, "they taste bland," she says. Flavors are noticeably muted since she started a ...